Abstract
Mitochondria are important for normal blood-cell development, and several diseases linked to mitochondrial DNA (mtDNA) show hematological manifestations. We recently generated a mouse strain deficient in expression of the mitochondrial pyrimidine nucleoside kinase thymidine kinase 2 (Tk2), showing that these mice exhibit progressive mtDNA depletion in multiple organs. We used this mouse strain as a model for mtDNA depletion syndromes to investigate the effects of mtDNA depletion on hematopoiesis. MtDNA levels in spleen from the Tk2-deficient mice were decreased 50%, but in contrast to all other investigated organs, both thymus and peripheral blood leukocytes showed normal mtDNA levels. Analysis of peripheral blood and cell populations in spleen, thymus, and bone marrow showed normal findings in the Tk2-deficient mice. The total rates of thymidine phosphorylation—which also include phosphorylation catalyzed by cytosolic Tk 1—in both spleen and thymus from wild-type mice were >50-fold higher than in liver, brain, and muscle. In summary, our data show that blood cells are less dependent on mitochondrial Tk2 compared with several other tissues and that these cells can synthesize deoxyribonucleotides required for mtDNA replication by alternative pathways such as phosphorylation of thymidine by cytosolic Tk1.
Similar content being viewed by others
Abbreviations
- ConA:
-
concanavalin A
- DGUOK:
-
deoxyguanosine kinase
- dCyd:
-
deoxycytidine
- dCK:
-
deoxycytidine kinase
- dThd:
-
deoxythymidine
- dNTP:
-
deoxyribonucleoside triphosphate
- dTTP:
-
deoxythymidine triphosphate
- LPS:
-
lipopolysaccharide
- mtDNA:
-
mitochondrial DNA
- p53R2:
-
p53-inducible ribonucleotide reductase subunit 2
- RR:
-
ribonucleotide reductase
- Tk1:
-
thymidine kinase 1
- Tk2:
-
thymidine kinase 2
References
Alberio S, Mineri R, Tiranti V, Zeviani M (2007) Depletion of mtDNA: syndromes and genes. Mitochondrion 7:6–12
Arnér ES, Spasokoukotskaja T, Eriksson S (1992) Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem Biophys Res Commun 188:712–718
Barth PG, Valianpour F, Bowen VM, Lam J, Duran M, Vaz FM, Wanders RJ (2004) X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet 126A:349–354
Eriksson S, Munch-Petersen B, Kierdaszuk B, Arnér E (1991) Expression and substrate specificities of human thymidine kinase 1, thymidine kinase 2 and deoxycytidine kinase. Adv Exp Med Biol 309B:239–243
Finsterer J (2007) Hematological manifestations of primary mitochondrial disorders. Acta Haematol 118:88–98
Fischel-Ghodsian N, Bohlman MC, Prezant TR, Graham JM Jr, Cederbaum SD, Edwards MJ (1992) Deletion in blood mitochondrial DNA in Kearns-Sayre syndrome. Pediatr Res 31:557–560
Goel HC, Prakash H, Ali A, Bala M (2007) Podophyllum hexandrum modulates gamma radiation-induced immunosuppression in Balb/c mice: implications in radioprotection. Mol Cell Biochem. Jan;295(1-2):93–103
Götz A, Isohanni P, Pihko H et al (2008) Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome. Brain 131:2841–2850
Johansson M, Karlsson A (1997) Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2. J Biol Chem 272:8454–8458
Leung TF, Hui J, Shoubridge E et al (1999) Aplastic anaemia in association with Kearns-Sayre syndrome. J Inherit Metab Dis 22:86–87
Mandel H et al (2001) The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29:337–341
Muraki K, Nishimura S, Goto Y, Nonaka I, Sakura N, Ueda K (1997) The association between haematological manifestation and mtDNA deletions in Pearson syndrome. J Inherit Metab Dis 20:697–703
Oskoui M et al (2006) Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol 63:1122–1126
Park CB et al (2007) MTERF3 is a negative regulator of mammalian mtDNA transcription. Cell 130:273–285
Pontarin G, Gallinaro L, Ferraro P, Reichard P, Bianchi V (2003) Origins of mitochondrial thymidine triphosphate: dynamic relations to cytosolic pools. Proc Natl Acad Sci USA 100:12159–12164
Pontarin G, Ferraro P, Håkansson P, Thelander L, Reichard P, Bianchi V (2007) p53R2-dependent ribonucleotide reduction provides deoxyribonucleotides in quiescent human fibroblasts in the absence of induced DNA damage. J Biol Chem 282:16820–16828
Rampazzo C, Fabris S, Franzolin E, Crovatto K, Frangini M, Bianchi V (2007) Mitochondrial thymidine kinase and the enzymatic network regulating thymidine triphosphate pools in cultured human cells. J Biol Chem 282:34758–34769
Rylova SN, Mirzaee S, Albertioni F, Eriksson S (2007) Expression of deoxynucleoside kinases and 5′-nucleotidases in mouse tissues: implications for mitochondrial toxicity. Biochem Pharmacol 74:169–175
Rötig A, Cormier V, Blanche S et al (1990) Pearson’s marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 86:1601–1608
Saada A et al (2001) Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29:342–344
Saada A, Shaag A, Elpeleg O (2003) mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency. Mol Genet Metab 79:1–5
Socolovsky M, Nam H-S, Fleming MD, Haase VH, Brugnara C, Lodish HF (2001) Ineffective erythropoiesis in Stat5a/5b/ mice due to decreased survival of early erythroblasts. Blood 98:3261–3273
Toy G et al (2010) Requirement for deoxycytidine kinase in T and B lymphocyte development. Proc Natl Acad Sci USA Early Edition www.pnas.org/cgi/doi/10.1073/pnas.0913900107
Van Rompay AR, Johansson M, Karlsson A (2003) Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases. Pharmacol Ther 100:119–139
Wu et al (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biology 10:R130
Zhou X, Solaroli N, Bjerke M, Stewart JB, Rozell B, Johansson M, Karlsson A (2008) Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice. Hum Mol Gen 17:2329–2335
Acknowledgements
This work was supported by grants from the Swedish Cancer Society.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Wolfgang Sperl
Competing interest: None declared.
Rights and permissions
About this article
Cite this article
Zhou, X., Johansson, M., Solaroli, N. et al. Hematopoiesis in the thymidine kinase 2 deficient mouse model of mitochondrial DNA depletion syndrome. J Inherit Metab Dis 33, 231–236 (2010). https://doi.org/10.1007/s10545-010-9102-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-010-9102-x